Rafael Holdings, Inc. (RFL): Revenue
$917.0K
Year ended 2025-07-31
$980.0K
Trailing 12 months to 2026-04-30
+30.8%
3-year compound annual growth
-28.5%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | $917.0K | +44.0% | 2025-10-29, From 2024-08-01 |
| 2024-07-31 | $637.0K | +128.3% | 2025-10-29, From 2023-08-01 |
| 2023-07-31 | $279.0K | -32.0% | 2024-12-20, From 2022-08-01 |
| 2022-07-31 | $410.0K | -48.9% | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | $802.0K | -83.7% | 2022-10-31, From 2020-08-01 |
| 2020-07-31 | $4.91M | -0.4% | 2021-10-18, From 2019-08-01 |
| 2019-07-31 | $4.93M | +12.8% | 2020-10-29, From 2018-08-01 |
| 2018-07-31 | $4.37M | -22.2% | 2019-10-04, From 2017-08-01 |
| 2017-07-31 | $5.62M | +0.5% | 2018-10-15, From 2016-08-01 |
| 2016-07-31 | $5.59M | n/a | 2018-10-15, From 2015-08-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $917.0K | +44.0% |
| Rallybio Corp (RLYB) | 2025-12-31 | $858.0K | +34.9% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $1.00M | -82.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.01M | +65.5% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.03M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $815.4K | -67.7% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $1.12M | +42.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $1.14M | -34.6% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $1.17M | -92.5% |
Compare RFL, RLYB, STTK, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗